Literature DB >> 20093352

Tumor response to sunitinib malate observed in clear-cell sarcoma.

S Stacchiotti, F Grosso, T Negri, E Palassini, C Morosi, S Pilotti, A Gronchi, P G Casali.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20093352     DOI： 10.1093/annonc/mdp611

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  9 in total

1.  Clear cell sarcoma of the penis: a case report.

Authors:  Timothy Ito; Jonathan Melamed; Mary Ann Perle; Joseph Alukal
Journal:  Am J Clin Exp Urol       Date:  2015-04-25

2.  Phase II study of amrubicin (SM-5887), a synthetic 9-aminoanthracycline, as first line treatment in patients with metastatic or unresectable soft tissue sarcoma: durable response in myxoid liposarcoma with TLS-CHOP translocation.

Authors:  Sumati Gupta; Launce Gouw; Jennifer Wright; Sant Chawla; Debbie Pitt; Mark Wade; Ken Boucher; Sunil Sharma
Journal:  Invest New Drugs       Date:  2016-02-20       Impact factor: 3.850

3.  Extraskeletal myxoid chondrosarcoma: tumor response to sunitinib.

Authors:  Silvia Stacchiotti; Gian Paolo Dagrada; Carlo Morosi; Tiziana Negri; Antonella Romanini; Silvana Pilotti; Alessandro Gronchi; Paolo G Casali
Journal:  Clin Sarcoma Res       Date:  2012-10-11

4.  Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report.

Authors:  Marcella Tazzari; Elena Palassini; Barbara Vergani; Antonello Villa; Francesca Rini; Tiziana Negri; Chiara Colombo; Flavio Crippa; Carlo Morosi; Paolo G Casali; Silvana Pilotti; Silvia Stacchiotti; Licia Rivoltini; Chiara Castelli
Journal:  BMC Cancer       Date:  2015-02-14       Impact factor: 4.430

Review 5.  Systemic treatment in advanced soft tissue sarcoma: what is standard, what is new.

Authors:  Anna Maria Frezza; Silvia Stacchiotti; Alessandro Gronchi
Journal:  BMC Med       Date:  2017-06-02       Impact factor: 8.775

Review 6.  Anti-Angiogenic Agents in Management of Sarcoma Patients: Overview of Published Trials.

Authors:  Pierre-Yves Cren; Loïc Lebellec; Thomas Ryckewaert; Nicolas Penel
Journal:  Front Oncol       Date:  2020-11-24       Impact factor: 6.244

7.  Clinical Experience with Apatinib and Camrelizumab in Advance Clear Cell Sarcoma: A Retrospective Study.

Authors:  Jiaqiang Wang; Shilei Gao; Yonghao Yang; Xu Liu; Peng Zhang; Shuping Dong; Xin Wang; Weitao Yao
Journal:  Cancer Manag Res       Date:  2021-12-03       Impact factor: 3.989

8.  Systemic treatment of advanced clear cell sarcoma: results from a retrospective international series from the World Sarcoma Network.

Authors:  A Smrke; A M Frezza; C Giani; N Somaiah; M Brahmi; A M Czarnecka; P Rutkowski; W Van der Graaf; G G Baldi; E Connolly; F Duffaud; P H Huang; H Gelderblom; V Bhadri; P Grimison; A Mahar; S Stacchiotti; R L Jones
Journal:  ESMO Open       Date:  2022-06-17

9.  Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS).

Authors:  Xavier Garcia del Muro; Enrique de Alava; Vicenç Artigas; Silvia Bague; Alejandro Braña; Ricardo Cubedo; Josefina Cruz; Nuria Mulet-Margalef; Jose A Narvaez; Oscar Martinez Tirado; Claudia Valverde; Ramona Verges; Joan Viñals; Javier Martin-Broto
Journal:  Cancer Chemother Pharmacol       Date:  2015-11-12       Impact factor: 3.333
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.